Shishir Bankapur signed his first customers before he formally incorporated the company. That was in 2022. By September 2026, his startup Helogen had secured a $7.1 million seed round and a NASA TechLeap Prize [Yahoo Finance, September 2026] [BioSpace, Unknown]. The bet is that the most valuable products for Earth will be made off it, in the quiet, persistent microgravity of low Earth orbit.
Bankapur’s company is not selling rides to space. It is selling the factory. Helogen’s initial product, called HEL-IOS, is an autonomous, zero-crew orbital platform designed to cultivate, process, and analyze biological materials [fundup.ai, Unknown]. The target customers are biopharma and life sciences firms seeking to produce advanced protein polymers, human tissue models, and proprietary biomaterials under conditions impossible to replicate in a terrestrial lab [helogen.com, Unknown].
The manufacturing wedge in orbit
Helogen’s wedge is specificity. While other new space ventures focus on launch, communications, or Earth observation, the company is building infrastructure for a single industrial process. Microgravity eliminates convective flows and sedimentation, allowing for purer crystal structures and more uniform tissue growth. This is not speculative research. The company claims a partnership with LambdaVision to produce artificial-retina protein films outside the International Space Station [fundup.ai, Unknown].
The HEL-IOS platform combines cultivation, environmental control, and real-time analytics into one flexible system [helogen.com, Unknown]. It is designed to operate autonomously, a critical feature for reducing the cost and complexity of crewed missions. The company says it has already flown two previous missions and is developing its first dedicated spacecraft [Yahoo Finance, September 2026].
Funding and the investor syndicate
The recent seed financing provides the capital to move from demonstration to operational scale. The round was co-led by RRE Ventures and Oceans, with participation from One Way Ventures, Blisce, AUM, Aurelia Foundry, and Mana VC [Yahoo Finance, September 2026]. The syndicate blends deep-tech and frontier technology investors with those experienced in biotech and hardware.
The capital coincides with planned operational tempo. Helogen has announced two in-orbit manufacturing missions for October 2026, aimed at advancing its biomaterial production capabilities [Yahoo Finance, September 2026]. The NASA TechLeap Prize, won in 2025, provides non-dilutive funding and significant validation within the agency’s commercial ecosystem.
| Round | Date | Amount | Lead Investors |
|---|---|---|---|
| Seed | September 2026 | $7.1M | RRE Ventures, Oceans |
The sparse public record
For a company with such an ambitious physical product, the public footprint is notably lean. Much of the available information comes from the company’s own materials, job listings, and startup databases [Perplexity Sonar Pro Brief, Unknown]. Beyond founder and CEO Shishir Bankapur, there is little independently verified detail on the full executive team. A third-party analyst report explicitly noted it found no listed founders or executive-team members beyond the CEO [The Venture Codex, Unknown].
This opacity presents a clear due diligence hurdle. However, it is not uncommon for early-stage deep-tech companies operating in regulated, partnership-driven fields. Traction is measured in signed customers and flown missions, not social media followers. Helogen’s claims of early customer commitments and its NASA prize are tangible, if privately verified, counters to the sparse public narrative.
What enterprise buyers are watching
The commercial logic for Helogen rests on a few critical unlocks. Biopharma customers are notoriously risk-averse and require flawless, reproducible science. The company must demonstrate not just that it can produce a material in space, but that it can do so at a cost and quality that justifies the orbital premium. The planned October missions are a key proof point.
Success also depends on the maturation of the broader commercial space infrastructure. Helogen’s platform is reportedly designed for compatibility with future commercial stations like Starlab [fundup.ai, Unknown]. The company’s reported acquisition of Vellon Space in April 2025, aimed at expanding into India’s space and biotech sectors, suggests a parallel strategy to build its own operational and market access capabilities [Globenewswire, April 2025].
The next twelve months
The immediate roadmap is hardware-heavy. The two October missions will test core systems. Hiring is focused on engineering, with open roles for a Lead Vehicle Design Engineer and a Mechanical Engineer II in Los Angeles [helogen.com/careers, September 2026]. A founding Marketing Lead role suggests a coming shift from technology development to commercial storytelling.
The key questions are operational. Can Helogen transition from flying payloads on third-party vehicles to operating its own dedicated HEL-IOS platform? Will the biomaterials produced command the premium prices needed to support the capital intensity of space manufacturing? The $7.1 million seed round, led by RRE Ventures and Oceans, is a vote of confidence in Bankapur’s answer. The next check will likely be larger, and will depend on data downloaded from orbit this fall.
Sources
- [Yahoo Finance, September 2026] Helogen Announces October Missions to Advance In-Orbit Manufacturing | https://finance.yahoo.com/healthcare/articles/helogen-announces-october-missions-advance-140000025.html
- [BioSpace, Unknown] Helogen Wins NASA TechLeap Prize | Source not available
- [fundup.ai, Unknown] Helogen Company Profile | https://fundup.ai/recently-funded-startups/company/a7c765d0bfb5ae3b4ad71873f436c337a205ec671e48ce1e16610f5e21124942/helogen
- [helogen.com, Unknown] Helogen Corporate Website | https://www.helogen.com/
- [Perplexity Sonar Pro Brief, Unknown] Helogen Research Brief | Source not available
- [The Venture Codex, Unknown] Helogen Company Profile | https://theventurecodex.com/companies/helogen
- [Globenewswire, April 2025] Helogen Corporation Acquires Vellon Space | https://www.globenewswire.com/news-release/2025/04/30/3071415/0/en/Helogen-Corporation-Acquires-Vellon-Space-to-Expand-Reach-into-India-s-Space-and-Biotechnology-Sectors.html
- [helogen.com, September 2026] Helogen Careers Page | https://www.helogen.com/careers